Controlled Antenatal Thyroid Screening II: effect of treating maternal sub-optimal thyroid function on child behaviour.

Icon for Silverchair Information Systems Related Articles

Controlled Antenatal Thyroid Screening II: effect of treating maternal sub-optimal thyroid function on child behaviour.

J Clin Endocrinol Metab. 2019 Oct 29;:

Authors: Hales C, Taylor PN, Channon S, McEwan K, Thapar A, Langley K, Muller I, Draman MS, Dayan C, Gregory JW, Okosieme O, Lazarus JH, Rees DA, Ludgate M

Abstract
CONTEXT & OBJECTIVES: The Controlled Antenatal Thyroid Screening (CATS) study was the first randomised controlled trial to investigate effects of treating suboptimal-gestational-thyroid-function (SGTF) on child cognition. Since observational studies indicated that SGTF may also increase symptoms of autism and attention deficit hyperactivity disorder (ADHD), the CATS cohort was used to investigate whether treatment of mothers affected their children’s behavior.
DESIGN & PARTICIPANTS: Mothers (N=475) completed 3 questionnaires, strengths and difficulties (SDQ), attention deficit hyperactivity disorder (ADHD) and social communication (SCQ, used as a screen for autism spectrum disorder (ASD)), about their children (aged 9.5 years). Group comparisons of total scores, numbers of children above clinical thresholds and association between high maternal FT4 (>97.5th percentile of the UK cohort, ‘over-treated’) and child neurodevelopment were reported.
RESULTS: There were no differences in total scores between normal-GTF (n=246), treated (n=125) and untreated (n=104) SGTF groups. More children of treated mothers scored above clinical thresholds, particularly the over-treated. Scores were above thresholds in SDQ conduct 22% vs 7%, SCQ total scores 7% vs 1%, and ADHD hyperactivity 17% vs 5% when comparing over-treated (n=40) and untreated (N=100) respectively. We identified significantly higher mean scores for SDQ conduct (adjusted mean difference (AMD) 0.74, 95% confidence interval (CI) 0.021 to 1.431, P=0.040, effect size 0.018) and ADHD hyperactivity (AMD 1.60, CI 0.361 to 2.633, P=0.003, effect size 0.028) comparing over-treated with normal-GTF children.
CONCLUSIONS: There was no overall association between SGTF and offspring ADHD, ASD or behavior questionnaire scores. However, children of ‘over-treated’ mothers displayed significantly more ADHD symptoms and behavioral difficulties than normal-GTF. Thyroxine supplementation during pregnancy requires monitoring to avoid over-treatment.

PMID: 31665323 [PubMed – as supplied by publisher]

via https://www.ncbi.nlm.nih.gov/pubmed/31665323?dopt=Abstract